Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NewGam in Primary Immunodeficiency Diseases
NCT01012323Phase 3Completed
- Sponsor
- Octapharma
- Start
- Jan 2010
- Primary completion
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in primary immunodeficiency disease (PID), sponsored by Octapharma. Started Jan 2010; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
primary immunodeficiency disease (PID)
Beyond the preview
Go deeper on NCT01012323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01012323.